Human genetics research exploring metabolic regulation and disease risk, previewing an article that examines gene-based discoveries and potential therapeutic pathways.
Key Takeaways
- Analysis of over one million exomes identified 59 metabolism-related genes enriched in liver and adipose expression
- Heterozygous loss-of-function FNIP1 carriers showed lower triglycerides, less liver fat, and better glycemic control
- FNIP1 heterozygotes had roughly 60% lower odds of a composite cardiometabolic outcome including CAD and diabetes